Vitadx

The company develops artificial intelligence solutions for the early detection of cancer, specifically utilizing deep learning and computer vision to analyze digitized cytology slides. Its primary product, VisioCyt Bladder, is a non-invasive test designed for the diagnosis and monitoring of bladder cancer using urine samples. The technology is based on French research and is protected by multiple patents to assist medical professionals in patient management.